STANOVA 10
STANOVA‑10 Tablet by NovaTech Sciences contains Stanozolol (CAS 10418‑03‑8). Trusted manufacturer, supplier, and exporter of pharmaceutical‑grade anabolic support for strength, performance, and muscle growth.
CAS Number: 10418-03-08
STANOVA 10 is indicated for individuals seeking enhanced muscle strength, lean muscle retention, and improved physical performance. It is also used in controlled medical therapy for tissue repair, anabolic recovery, and protein synthesis support under physician guidance.
STANOVA 10 by Nova Techsciences is presented as a tablet formulation containing Stanozolol 10 mg. Stanozolol is a synthetic anabolic-androgenic steroid identified by CAS Number 10418-03-8 and the molecular formula C21H32N2O. It is chemically distinct from testosterone esters and other injectable anabolic compounds.
This page provides general product-identification, quality and safety information. It is not a replacement for authorised prescribing information, an approved patient leaflet or advice from a qualified healthcare professional.
Product Overview
Key STANOVA 10 information includes:
- Product name: STANOVA 10
- Active compound: Stanozolol
- Strength: 10 mg per tablet
- Dosage form: Oral tablet
- CAS Number: 10418-03-8
- Brand: Nova Techsciences
The complete label should clearly identify the active ingredient, excipients, tablet quantity, batch number, manufacturing date, expiry date and approved storage conditions. Information displayed online should remain consistent with the packaging, catalogue, laboratory documents and Certificate of Analysis.
Quality and Documentation
Tablet manufacturing requires documented controls for active-ingredient identity, strength, content uniformity, dissolution, impurities and microbiological quality. Finished tablets should also be assessed for appearance, weight consistency, packaging integrity and stability throughout their stated shelf life.
Every STANOVA 10 batch should have a unique number linked to its production history and laboratory results. Claims involving purity, pharmaceutical quality or manufacturing standards should only be published when supporting records are available.
For the United Kingdom and Netherlands, Nova Techsciences should clearly disclose whether the product holds the necessary marketing authorisation. The MHRA regulates medicines in the UK, while the Dutch Medicines Evaluation Board manages national medicine authorisations and pharmacovigilance in the Netherlands.
Safety Information
Stanozolol belongs to the anabolic-steroid category. Unsupervised use may cause serious cardiovascular, hormonal, reproductive, liver and psychological complications. The NHS states that anabolic steroids are prescription-only medicines in the UK and warns that non-medical use may cause serious side effects and dependence.
STANOVA 10 should not be presented for self-medication, unsupervised performance enhancement or use by minors. It is also prohibited in competitive sport under the World Anti-Doping Agency’s anabolic-agent category.
Related Nova Techsciences Products
TESTOVA BASE
TESTOVA BASE is presented as a non-esterified testosterone injectable formulation. It is chemically different from Stanozolol and requires separate documentation covering its exact strength, excipients, sterility testing, storage conditions, contraindications and applicable prescription status.
TESTOVA PP
TESTOVA PP contains Testosterone Phenylpropionate, an esterified testosterone compound associated with CAS Number 1255-49-8. Its pharmaceutical profile differs from an oral Stanozolol tablet, and its composition, batch testing, professional monitoring and regulatory status should be documented independently.
DROSTANOVA P
DROSTANOVA P is a Drostanolone Propionate injectable product associated with CAS Number 521-12-0. Drostanolone and Stanozolol are separate anabolic-androgenic substances with different chemical structures, formulations, safety concerns and quality-control requirements.
TESTOVA E
TESTOVA E is presented as a Testosterone Enanthate injectable formulation. The enanthate ester differentiates it from non-esterified testosterone and shorter ester products. Its label should clearly identify its strength, ingredients, storage instructions, batch details and contraindications.
TESTOVA P
TESTOVA P contains Testosterone Propionate, identified by CAS Number 57-85-2. It is an injectable testosterone ester rather than an oral Stanozolol formulation. It requires separate sterility documentation, composition verification, medical supervision and country-specific regulatory review.
STANOVA 10 should be presented using accurate chemical identification, transparent quality records, clear regulatory status and balanced safety information. This creates a more reliable product page for healthcare professionals and regulatory reviewers without relying on unsupported performance claims.
Important Information & FAQs
Precautions & Contraindications
Precautions
- Use only under medical guidance.
- Do not exceed recommended dosage or cycle duration.
- Avoid alcohol or liver-stressing substances.
- Consult your doctor if taking other medications or supplements.
- Keep out of reach of children.
- Discontinue and seek medical help if unusual symptoms occur.
Contraindications
- Do not use if allergic to Stanozolol or tablet ingredients.
- Not recommended for individuals with liver, kidney, or heart problems.
- Avoid during pregnancy or breastfeeding.
- Use only under physician supervision for minors or medically prescribed cycles.
Related Products
AROMANOVA
High-potency Exemestane tablets for advanced estrogen control and PCT support.
CABERNOVA
Premium Cabergoline tablets for prolactin control, hormone support, and enhanced recovery.
CLOMINOVA
Clomiphene Citrate 50 mg tablets for post-cycle therapy, testosterone recovery, and hormonal balance.
ENCLOMINOVA
Premium Enclomiphene Citrate tablets for testosterone boosting, PCT recovery, and hormonal balance.